Mark D. Chatfield
- Health top 2%
- Otorhinolaryngology top 2%
-
- Infant Development and Preterm Care 19
-
- Cerebral Palsy and Movement Disorders 17
-
- Respiratory viral infections research 16
- Pneumonia and Respiratory Infections 15
-
- Family and Disability Support Research 13
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 12
- Cystic Fibrosis Research Advances 10
-
- Bacterial Identification and Susceptibility Testing 10
- Co-authors
- Fiona E. MatthewsCarol BrayneAdrian ManderPeter S MorrisAnne B. ChangSusan A. JebbRoss AndrewsSteven Y. C. Tong
- Journals
- Journal of Clinical Oncology (11 papers)Developmental Medicine & Child Neurology (8 papers)BMJ Open (7 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Mark D. Chatfield
192 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 188
- Health 370
- Otorhinolaryngology 175
- Applied Microbiology and Biotechnology 71
- Neuropsychology and Physiological Psychology 49
- Public Health, Environmental and Occupational Health 821
Countries citing papers authored by Mark D. Chatfield
This map shows the geographic impact of Mark D. Chatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Chatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Chatfield more than expected).
Fields of papers citing papers by Mark D. Chatfield
This network shows the impact of papers produced by Mark D. Chatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Chatfield. The network helps show where Mark D. Chatfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark D. Chatfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 17 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 15 | |
| 17 | 2019 | 10 | |
| 18 | 2019 | 4 | |
| 19 | 2019 | 6 | |
| 20 | A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial | 2013 | 1 |
About Mark D. Chatfield
Mark D. Chatfield is a scholar working on Applied Microbiology and Biotechnology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine, having authored 197 papers that have together received 4.5k indexed citations. Recurring topics across this work include Infant Development and Preterm Care (19 papers), Cerebral Palsy and Movement Disorders (17 papers), Respiratory viral infections research (16 papers), Pneumonia and Respiratory Infections (15 papers), Family and Disability Support Research (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Cystic Fibrosis Research Advances (10 papers) and Bacterial Identification and Susceptibility Testing (10 papers). The work is most often cited by research in Health (370 citations), Otorhinolaryngology (175 citations) and Applied Microbiology and Biotechnology (71 citations). Mark D. Chatfield has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Fiona E. Matthews, Carol Brayne, Adrian Mander, Peter S Morris, Anne B. Chang, Susan A. Jebb, Ross Andrews, Steven Y. C. Tong, Amanda Leach and Jonathan R. Carapetis. Their work appears in journals such as Journal of Clinical Oncology, Developmental Medicine & Child Neurology, BMJ Open, Trials and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.